SEN-JAM PHARMACEUTICAL
Sen-Jam Pharmaceutical is a medical company developing novel pharmaceutical solutions for large unmet needs using the development pathway. The company focused on improving clinical outcomes for patients battling opioid use disorder, viral respiratory infections from coronaviruses such as COVD-19 and other painful inflammation and toxin-induced conditions, including arthritis, vaccinations, and even the infamous hangover. Sen-Jam Pharmaceutical develops consumer healthcare products that help peo... ple stay strong by mitigating common side effects from medicines and everyday living. The company global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph. Sen-Jam Pharmaceutical was founded in 2014 and is headquartered in Huntington, New York, United States.
SEN-JAM PHARMACEUTICAL
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2014-01-01
Address:
Huntington, New York, United States
Country:
United States
Website Url:
http://www.sen-jam.com
Total Employee:
11+
Status:
Active
Contact:
201.400.8083
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome Apache Wordpress Plugins
Similar Organizations
Acuity Pharmaceuticals
Acuity Pharmaceuticals product-focused ophthalmic pharmaceutical company applying its proprietary technology to the treatment.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Employees Featured
Founder
Investors List
StartUp Health
StartUp Health investment in Seed Round - Sen-Jam Pharmaceutical
Official Site Inspections
http://www.sen-jam.com Semrush global rank: 5.24 M Semrush visits lastest month: 1.56 K
- Host name: 74.58.180.107.host.secureserver.net
- IP address: 107.180.58.74
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Sen-Jam Pharmaceutical"
Sen-Jam Pharmaceutical - Crunchbase Company âŠ
Sen-Jam Pharmaceutical is a medical company developing novel pharmaceutical solutions for large unmet needs using the development pathway. The company focused on improving clinical outcomes for patients battling opioid use âŠSee details»
About Us - Sen-Jam Pharmaceutical
Sen-Jam innovates to eliminate many painful side effects. Whether they come from medicine or everyday living. Our product line is based on Opioid Free Pain Relief with GI Protection for âŠSee details»
Sen-Jam Pharmaceutical Advances First in Class FDA-Regulated âŠ
Nov 19, 2024 The trial, conducted by a leading clinical research organization in Australia, ... Sen-Jam Pharmaceutical Christine Leonard [email protected] 781-913-1902. SOURCE Sen âŠSee details»
SJP Enters Powerful Partnership with CMC expert, KVK-Tech
HUNTINGTON, N.Y., March 22, 2022 /PRNewswire/ â Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by âŠSee details»
Sen-Jam Pharmaceutical Advances First in Class FDA-Regulated âŠ
Nov 19, 2024 Sen-Jam Pharmaceutical announced recently the initiation of a Phase 2 clinical trial for SJP-001, positioning it to become the first FDA-approved therapeutic specifically âŠSee details»
Sen-JamPharmaceutical: Revolutionizing Healthcare by âŠ
Sen-Jam Pharmaceutical, founded in 2017 and based in Huntington, New York, is co-led by Jackie Iversen, RPh MS, who serves as the Chief Clinical Officer. Jackie is a visionary âŠSee details»
Sen-Jam Pharmaceutical - Funding, Financials, Valuation & Investors
Nov 8, 2018 Sen-Jam Pharmaceutical is a medical company developing novel pharmaceutical solutions for large unmet needs using the development pathway. ... How much funding has âŠSee details»
Sen-Jam Pharmaceutical, the World's Most Resourceful Drug
HUNTINGTON, N.Y., Oct. 14, 2022 /PRNewswire/ -- Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing âŠSee details»
Sen-Jam Pharmaceutical Partners with Specialty Pharmaceutical ...
Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing existing molecules for novel uses, has âŠSee details»
Sen-Jam Pharmaceutical Partners with Specialty âŠ
Mar 22, 2022 Sen-Jam Pharmaceutical has entered a development, manufacturing, distribution, and license agreement with KVK-Tech. This is a monumental milestone for the company and great news for their ...See details»
Sen-Jam's First-in-Class FDA-Regulated Hangover Cure Enters âŠ
Nov 20, 2024 N ew York-based Sen-Jam Pharmaceutical has launched a Phase 2 clinical trial for its hangover prevention therapy, SJP-001.The trial, conducted in Australia, aims to âŠSee details»
Sen-Jam Pharmaceutical Partners with Specialty ... - KVK TECH
Mar 23, 2022 Sen-Jam Pharmaceutical has entered a development, manufacturing, distribution, and license agreement with KVK-Tech. This is a monumental milestone for the company and âŠSee details»
WeFunder Campaign closes with a huge success of over $1M âŠ
Jul 29, 2022 Sen-Jam repurposes small molecules to develop novel therapeutics for large unmet needs with a focus on improving clinical outcomes. Using patented proprietary technology and âŠSee details»
Sen-Jam Pharmaceutical Advances First in Class FDA-Regulated âŠ
Nov 19, 2024 The trial, conducted by a leading clinical research organization in Australia, marks a pivotal milestone in addressing a significant global health and productivity challenge. SJP âŠSee details»
Life Science Startup Positioned to Revolutionize Pain and âŠ
Sep 8, 2021 Sen-Jam Pharmaceutical's vision is to improve societal wellbeing by developing therapeutics that are safe, efficacious, and accessible by repurposing small molecules to âŠSee details»
News - Sen-Jam Pharmaceutical
In support of Sen-Jam's mission to improve societal well-being, our Patent Application No. 11,129,803B2 for Methods and Compositions to Inhibit Tolerance to Opioids was granted by âŠSee details»
Sen-Jam Pharmaceutical is developing a promising alcohol âŠ
Mar 16, 2022 Using patented proprietary technology and the accelerated 505(b)2 pathway, Sen-Jam is on a mission to revolutionize pain treatment and the business of pain relief. Investor âŠSee details»
Sen-Jam Pharmaceutical, the World's Most Resourceful Drug âŠ
Oct 14, 2022 Sen-Jam Pharmaceutical is engaging leading Crowdfunding platform, StartEngine to raise funding to advance their critical therapeutics, signaling them as the world's most âŠSee details»
Blog - Sen-Jam Pharmaceutical
Mar 22, 2024 The latest updates, press releases, and other news from Sen-Jam. Biomarker Innovators Lean In As Co-Founder, CCO, Jackie Iversen RPh MS Shares SJPâs Vision for âŠSee details»